Skip to content

Clinical study on treatment of diabetic foot with integrated traditional Chinese and western medicine

Clinical study on treatment of diabetic foot with integrated traditional Chinese and western medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004331
Enrollment
Unknown
Registered
2020-10-25
Start date
2020-11-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot

Interventions

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria for diabetic foot disease infection; 2. Wagner classification II~IV; 3. Those who meet the diagnostic criteria of gangrene damp-heat-toxin-excessive syndrome; 4. Age between 18 and 80 years old, regardless of gender; 5. Informed consent, signed informed consent form, and voluntarily take the test.

Exclusion criteria

Exclusion criteria: 1. Combined with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system: such as blood creatinine>1.5 times the upper limit of normal, ALT > 1.5 times the upper limit of normal, proteinuria >+ (>30mg/dl) , Arrhythmia with clinical significance; 2. Severe infections, multiple system dysfunction or failure, and septic shock; 3. Pregnant or lactating women; 4. Patients with allergies; 5. Mental patients; 6. Malignant tumors or AIDS patients; 7. According to the researcher's judgment, other personal history that reduces the possibility of enrollment or complicates enrollment, such as frequent changes in the work environment, may easily cause loss to follow-up; 8. Subjects who are participating in clinical studies of other drugs.

Design outcomes

Primary

MeasureTime frame
amputation rate;

Secondary

MeasureTime frame
Interleukin 2;C reactive protein;Interleukin 6;TCM syndrome score;tumor necrosis factor alpha;Interleukin 4;blood routine;erythrocyte sedimentation rate;Interleukin 10;wound area;procalcitonin;

Countries

China

Contacts

Public ContactHuafa Que

Longhua Hospital Shanghai University of Traditional Chinese Medicine

huafaque@126.com+86 18917763218

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026